Skip to Main Content

NIH Public Access Policy

Instructions and resources to help the UCI research community comply with the NIH Public Access Policy.

Email this link:

Citing Interim Research Products

NIH Encourages Use of Interim Research Products 

On 3/24/2017, NIH released a notice (Reporting Preprints and Other Interim Research Products, NOT-OD-17-050) stating that interim research products such as preprints and preregistered protocols can soon be cited where other research products are cited. This includes the NIH Biosketch, Research Performance Progress Report (RPPR) section C, and other PHS 398 forms.  The change is effective for applications submitted for the May 25, 2017 due date and thereafter, and for RPPRs submitted on or after May 25, 2017.

  • NIH encourages investigators to use interim research products, but does not required their use.
  • Interim Research Products are complete, public research products that are not final. This includes preprints and preregistered protocols.  
  • Preprints do not fall under the NIH Public Access Policy.
  • This guide notice does not apply to clinical trial registration.  See ClinicalTrials.gov about registration of clinical trial protocols.

 

Citing interim research products in applications, proposals and reports

  • Must include the Digital Object Identifier (DOI) and the Object type (e.g. preprint, protocol) in the citation.
  • List any information about the document version (e.g. most recent date modified), and if relevant, the date the product was cited.  See example below:

    • Bar DZ, Atkatsh K, Tavarez U, Erdos MR, Gruenbaum Y, Collins FS. Biotinylation by antibody recognition- A novel method for proximity labeling. BioRxiv 069187 [Preprint]. August 11, 2016 [cited 2017 Jan 12].  Available from: https://doi.org/10.1101/069187.

 

For the full report, please go to: NIH NOT-OD-17-050: Reporting Preprints and Other Interim Research Products.

CITING ICTS Grant

Cite The Grant - NIH Required Language

NIH Funding Acknowledgment for ICTS Publications and Projects:  

Any publications, patents, or projects that benefit from any ICTS resources (including the use of ICTS services and UCI Health Research Toolkit such as REDCap must credit the ICTS Grant. Please use the following language:

The project described was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1 TR001414. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
 

*Please note: If you have received training or funding (TL1 or KL2) through the ICTS a different citation is required. Please contact: Diana Vigil, dvigil1@uci.edu for additional information.

 

Helpful Contacts

Consult  the Library

  • Email your NIH Public Access question to: nihgroup@uci.edu
  • Schedule a Digital Scholarship Consultation for assistance with any of your information needs below:
  • Receive help with the NIH public access policy, create My NCBI user account, and link your ORCiD,
  • Generate a biosketch with SciENcv,
  • Data management plans, and
  • Increasing research impact. 

 

Other Contacts

UCI Office of Research 

NIH eRA Commons Help Desk Desk

  • Submit a web ticket (preferred method of contact)
  • Toll-free: 1-866-504-9552 (Press 1 for eRA Commons or ASSIST)

​My NCBI Support Center

NIH Policy general questions